IGeL kritisch betrachtet: Intraartikuläre Injektion von Hyaluronsäure bei Gonarthrose

Zusammenfassung

Hintergrund und Problemstellung: Die intraartikuläre Injektion von Hyaluronsäure und deren Derivaten wird im Rahmen der Therapie von degenerativen Gelenkerkrankungen (z. B. Gonarthrose) als individuelle Gesundheitsleistung (IGeL) angeboten. Es wurde die Frage untersucht, ob die intraartikuläre Injektion von Hyaluronsäurepräparaten im Vergleich zu anderen Behandlungsmethoden bei Gonarthrose effektiv ist.

Methode: Im Rahmen eines selektiven Reviews wurde eine intensive Literaturrecherche in den Datenbanken MEDLINE sowie in der Cochrane Database of Systematic Reviews und Cochrane CENTRAL durchgeführt.

Ergebnisse: Metaanalysen und systematische Übersichtsarbeiten zu diesem Themenkomplex sind rar und weisen eine hohe Heterogenität der Ergebnisse auf. Mögliche Hinweise auf einen Effekt intraartikulärer Injektionen von Hyaluronsäure im Sinne einer Verbesserung der Beschwerdeintensität und Beweglichkeit zeigten sich allenfalls bei Patienten mit mittelgradiger Gonarthrose. Viele diesbezügliche randomisierte kontrollierte Studien wurden jedoch von der Industrie finanziell unterstützt. Mögliche systematische Fehlerquellen (z. B. publication bias) sind daher nicht auszuschließen.

Schlussfolgerung: Eine eindeutige Überlegenheit der Effektivität von intraartikulär applizierter Hyaluronsäure bei Gonarthrose gegenüber anderen Therapieverfahren kann zurzeit aufgrund der heterogenen Ergebnisse der vorliegenden Studien nicht belegt werden. Daher kann eine intraartikuläre Injektionstherapie mit Hyaluronsäure bei Gonarthrose nicht generell empfohlen werden.

Abstract

Background and Problem: The intra-articular injection of hyaluronic acid and its derivatives is offered as a voluntary, non-covered health service (IGeL) to those undergoing therapy for degenerative joint illnesses (e.g. gonarthrosis). The question was examined whether the intra-articular injection of hyaluronic acid preparations is effective in the treatment of gonarthrosis in comparison to other methods.

Method: As part of a selective review, an intensive literature research was carried out in the MEDLINE database, as well as the Cochrane Database of Systematic Reviews and Cochrane CENTRAL.

Results: Meta-analyses and systematic overviews on this subject are rare and show widely differing results. Possible indications of the positive impact of intra-articular injections of hyaluronic acid in terms of discomfort relief and increased mobility were at best noticeable in patients with moderate gonarthrosis. However, many of the randomized controlled studies on the subject were financed by industry. Possible systematic error sources (e.g. publication bias) can therefore not be ruled out.

Conclusion: Judging by the heterogeneous results of the studies under review, intra-articular hyaluronic acid injections are not clearly more effective than other therapies in the treatment of gonarthrosis. An intra-articular hyaluronic acid injection therapy for the treatment of gonarthrosis can therefore not be generally recommended.

Schlüsselwörter

Hyaluronsäure - Osteoarthritis - Gonarthrose - Wirksamkeit - Nutzenbewertung

Key words

hyaluronic acid - osteoarthritis - gonarthrosis - efficacy - effectiveness

Literatur

• 1 Niethard F, Pfeil J. Orthopädie, Thieme Verlag, 5. Auflage 2005.
• 2 Saase JL van, Romunde LK van, Cats A. et al . Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations.  Ann Rheum Dis. 1989;  48 ((4)) 271-280
• 3 Akatsuka M, Yamamoto Y, Tobetto K. et al . In vitro effects of hyaluronan on prostaglandin E2 induction by interleukin-1 in rabbit articular chondrocytes.  Agents Actions. 1993;  38 ((1–2)) 122-125
• 4 Bellamy N, Campbell J, Robinson V. et al . Viscosupplementation for the treatment of osteoarhtritis of the knee.  , The Cochrane Database of Systematic Reviews 2006, Issue 2. Art No.: CD005321. DOI: 10.1002/14651858. CD005321.pub.2
• 5 Brouwer RW, Jakma TSC, Verhagen AP. et al . Braces and orthoses for treating osteoarthritis of the knee.  , The Cochrane Database of Systematic Reviews 2005, Issue 1. Art. No.: CD004020. DOI: 10.1002/14651858.CD004020.pub.2
• 6 Grecomoro G, La Sala F, Francavilla G. Rheologic changes in the synovial fluid of patients with gonarthritis induced by intraarticular infiltration of hyaluronic acid.  Int J Tissue React. 2001;  23 ((2)) 67-71
• 7 Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis.  J Rheumatol Suppl. 1993;  39 3-9
• 8 Balazs EA. Viscosupplementation for treatment of osteoarthritis: from initial discovery to current status and results.  Surg Technol Int.. 2004;  12 278-289 , Review
• 9 Rydell N, Balazs EA. Effect of intra-articular injection of hyaluronic acid on the clinical symptoms of osteoarthritis and on granulation tissue formation.  Clin Orthop Relat Res. 1971;  80 25-32
• 10 Goto M, Hanyu T, Yoshio T. et al . Intra-articular injection of hyaluronate (SI-6601D) improves joint pain and synovial fluid prostaglandin E2 levels in rheumatoid arthritis: a multicenter clinical trial.  Clin Exp Rheumatol.. 2001;  19 ((4)) 377-383
• 11 Gotoh S, Onaya J, Abe M. et al . Effects of the molecular weight of hyaluronic acid and its action mechanisms on experimental joint pain in rats.  Ann Rheum Dis.. 1993;  52 ((11)) 817-822
• 12 Shimazu A, Jikko A, Iwamoto M. et al . Effects of hyaluronic acid on the release of proteoglycan from the cell matrix in rabbit chondrocyte cultures in the presence and absence of cytokines.  Arthritis Rheum.. 1993;  36 ((2)) 247-253
• 13 Wobig M, Bach G, Beks P. et al . The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan.  Clin Ther.. 1999;  21 ((9)) 1549-1562
• 14 Kvam BJ, Fragonas E, Degrassi A. et al . Oxygen-derived free radical (ODFR) action on hyaluronan (HA), on two HA ester derivatives, and on the metabolism of articular chondrocytes.  Exp Cell Res.. 1995;  218 ((1)) 79-86
• 15 Grecomoro G, Martorana U, Di Marco C. Intra-articular treatment with sodium hyaluronate in gonarthrosis: a controlled clinical trial versus placebo.  Pharmatherapeutica. 1987;  5 ((2)) 137-141
• 16 Karatosun V, Unver B, Gocen Z. et al . Comparison of two hyaluronan drugs in patients with advanced osteoarthritis of the knee. A prospective, randomized, double-blind study with long term follow-up.  Clin Exp Rheumatol.. 2005;  23 ((2)) 213-218
• 17 Raynauld JP, Goldsmith CH, Bellamy N. et al . Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis.  Osteoarthritis Cartilage.. 2005;  13 ((2)) 111-119
• 18 Jubb RW, Piva S, Beinat L. et al . A one-year, randomised, placebo (saline) controlled clinical trial of 500–730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee.  Int J Clin Pract.. 2003;  57 ((6)) 467-474
• 19 Pham T, Le Henanff A, Ravaud P. et al . Evaluation of the symptomatic and structural efficacy of a new hyaluronic acid compound, NRD101, in comparison with diacerein and placebo in a 1 year randomised controlled study in symptomatic knee osteoarthritis.  Ann Rheum Dis.. 2004;  63 ((12)) 1611-1617 , Epub 2004 Aug 26
• 20 Altman RD, Akermark C, Beaulieu AD. et al . Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee.  Osteoarthritis Cartilage.. 2004;  12 ((8)) 642-649
• 21 Miltner O, Schneider U, Siebert CH. et al . Efficacy of intraarticular hyaluronic acid in patients with osteoarthritis--a prospective clinical trial.  Osteoarthritis Cartilage.. 2002;  10 ((9)) 680-686
• 22 Raynauld JP, Torrance GW, Band PA. et al . A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results.  Osteoarthritis Cartilage. 2002;  10 ((7)) 506-517
• 23 Karlsson J, Sjogren LS, Lohmander LS. Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study.  Rheumatology (Oxford). 2002;  41 ((11)) 1240-1248
• 24 Espallargues M, Pons JMV. Efficacy and safety of viscosupplementation with Hylan G-F 20 for the treatment of knee ostheoarthritis: A systematic review.  Int J Tech Ass Health Care. 2003;  19 ((1)) 41-56
• 25 Chou CL, Li HW, Lee SH. et al . Effect of Intra-articular Injection of Hyaluronic Acid in Rheumatoid Arthritis Patients with Knee Osteoarthritis.  J Chin Med Assoc.. 2008;  71 ((8)) 411-415
• 26 Petrella RJ, DiSilvestro MD, Hildebrand C. Effects of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial.  Arch Intern Med.. 2002;  162 ((3)) 292-298
• 27 Bunyaratavej N, Chan KM, Subramanian N. Treatment of painful osteoarthritis of the knee with hyaluronic acid.  Results of a multicenter Asian study. J Med Assoc Thai.. 2001;  84 ((Suppl 2)) S576-S581
• 28 Bellamy N, Bell MJ, Goldsmith CH. et al . The effectiveness of hylan G-F 20 in patients with knee os-teoarthritis: an application of two sets of response criteria developed by the OARSI and one set developed by OMERACT-OARSI.  Osteoarthritis Cartilage. 2005;  13 ((2)) 104-110
• 29 Lo G, La Valley M, Alindon T Mac. et al . Intra-articular Hyaluronic Acid in Treatment of Knee Ostheoarthritis.  JAMA. 2003;  290 ((23)) 3115-3121
• 30 Arrich J, Piribauer F, Mad P. et al . Intra-articular hyaluronic acid fort he treatment of ostheoarthritis of the knee: systematic review and meta-analysis.  CMAJ. 2005;  172 ((8)) 1-13
• 31 Jüni P, Reichenbach S, Trelle S. et al . Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial.  Arthritis Rheum.. 2007;  56 ((11)) 3610-3619
• 32 Conrozier T, Jerosch J, Beks P. et al . Pro-spective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study.  Arch Orthop Trauma Surg. 2008; 
• 33 Karatosun V, Unver B, Ozden A. et al . Intra-articular hyaluronic acid compared to exercise therapy in osteoarthritis of the ankle.  A prospective randomized trial with long-term follow-up. Clin Exp Rheumatol. 2008;  26 ((2)) 288-294
• 34 Migliore A, Granata M. Intra-articular use of hyaluronic acid in the treatment of osteoarthritis.  Clin Interv Aging. 2008;  3 ((2)) 365-369
• 35 Modaval A, Ferrer M, Choi HK. et al . Hyaluronic acid injections relieve knee pain.  J Fam Pract. 2005;  54 ((9)) 758-767
• 36 Wang CT, Lin J, Chang CJ. et al . Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials.  J Bone Joint Surgery Am. 2004;  86-A ((3)) 538-545
• 37 Mathies B. Effects of Viscoseal, a synovial fluid substitute, on recovery after arthroscopic partial meniscectomy and joint lavage.  Knee Surg Sports Traumatol Arthrosc.. 2006;  14 ((1)) 32-39 , Epub 2005 May 26
• 38 Auerbach B, Melzer C. Cross-linked hyaluronic acid in the treatment of osteoarthritis of the knee--results of a prospective randomized trial.  Zentralbl Chir. 2002;  127 ((10)) 895-899
• 39 Bayramoglu M, Karatas M, Cetin N. et al . Comparison of two dif-ferent viscosupplements in knee osteoarthritis – a pilot study.  Clin Rheumatol. 2003;  22 ((2)) 118-122
• 40 Roman JA, Chismol J, Morales M. et al . Intra-articular treatment with hyaluronic acid.  Comparative study of Hyalgan and Adant. Clin Rheumatol.. 2000;  19 ((3)) 204-206
• 41 Lee PB, Kim YC, Lim YJ. et al . Comparison between high and low molecular weight hyaluronates in knee osteoarthritis patients: open-label, randomized, multicentre clinical trial.  J Int Med Res.. 2006;  34 ((1)) 77-87
• 42 Torrance GW, Raynauld JP, Walker V. et al . A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic results.  Osteoarthritis Cartilage. 2002;  10 ((7)) 518-527
• 43 Charalambous CP, Tryfonidis M, Sadiq S. et al . Septic arthritis following intra-articular steroid injection of the knee – a survey of current practice regarding antiseptic technique used during intra-articular steroid injection of the knee.  Clin Rheumatol. 2003;  22 386-390
• 44 Pal B, Morris J. Perceived Risks of Joint Infection Following Intra-articular Corticosteroid Injections: A Survey of Rheumatologists.  Clin Rheumatol. 1999;  18 264-265
• 45 Schumacher HR, Chen L. Injectable corticosteroids in treatment of arthritis of the knee.  Am J Med. 2005;  118 1208-1214
• 46 Bernau A, Heeg P. Intraartikuläre Punktionen und Injektionen.  Orthopäde. 2003;  32 548-570

Korrespondenzadresse